Clinic
Doral Medical and Multi Specialty Facility LLC
Doral Medical and Multi Specialty Facility LLC was paid $7.77M by Medicaid between Apr 2020 and Dec 2024, across 186 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.
33Billing provider infoDORAL MEDICAL AND MULTI SPECIALTY FACILITY LLC
BROOKLYN, NY 11212
BROOKLYN, NY 11212
33aNPI1144693607assigned 11/05/2015
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$7.77M
24GClaims287,912
24DCodes billed186
24AFirst – last monthApr 2020 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in New York
Rank by total paid#15 of 118
Median peer was paid$372K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,450 | $8K | |
| 2021 | 12,987 | $320K | |
| 2022 | 34,608 | $1.65M | |
| 2023 | 131,231 | $2.32M | |
| 2024incomplete | 107,636 | $3.48M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 65,206 | 20,438 | $2.05M |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 8.2% | 13,608 | 10,488 | $635K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7.3% | 7,982 | 5,942 | $569K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 7.0% | 5,988 | 3,430 | $545K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.6% | 9,939 | 4,490 | $512K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.4% | 4,149 | 3,366 | $262K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.8% | 2,178 | 1,853 | $220K |
| G0445 | High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes | 2.5% | 2,319 | 2,242 | $195K |
| 99441 | 2.5% | 1,661 | 1,565 | $193K | |
| 20552 | 2.4% | 1,068 | 931 | $188K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.8% | 262 | 259 | $140K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 1.6% | 770 | 728 | $121K |
174 more codes
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.5% | 2,102 | $120K |
| 99443 | 1.5% | 2,217 | $119K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 1.4% | 1,409 | $112K |
| 99401 | 1.4% | 3,365 | $109K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.2% | 1,027 | $93K |
| 93880 | 1.2% | 238 | $91K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.2% | 509 | $91K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 1.1% | 528 | $87K |
| 93970 | 1.1% | 198 | $85K | |
| 99454 | 1.0% | 8,767 | $81K | |
| 99000 | <1% | 5,385 | $75K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 696 | $66K |
| 76942 | <1% | 389 | $65K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 882 | $65K |
| 96160 | <1% | 1,471 | $56K | |
| 99385 | <1% | 665 | $53K | |
| 11900 | <1% | 160 | $44K | |
| 11721 | <1% | 1,165 | $41K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 1,489 | $39K |
| 99442 | <1% | 729 | $37K | |
| 92201 | <1% | 589 | $37K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 194 | $33K |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 919 | $32K |
| 93925 | <1% | 94 | $32K | |
| 99457 | <1% | 5,678 | $29K | |
| 0002A | <1% | 983 | $27K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 363 | $26K |
| 0001A | <1% | 1,047 | $26K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 47 | $25K |
| 99386 | <1% | 227 | $23K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,296 | $23K |
| 99406 | <1% | 536 | $22K | |
| 20611 | <1% | 57 | $22K | |
| H0001 | Alcohol and/or drug assessment | <1% | 198 | $20K |
| 2000F | <1% | 14,413 | $17K | |
| 99091 | <1% | 296 | $13K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,666 | $12K |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | <1% | 100 | $12K |
| 93975 | <1% | 21 | $11K | |
| 86328 | <1% | 297 | $10K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 61 | $10K |
| 0003A | <1% | 292 | $10K | |
| 1159F | <1% | 8,690 | $10K | |
| 95250 | <1% | 60 | $9K | |
| 93015 | <1% | 58 | $8K | |
| 17110 | <1% | 34 | $8K | |
| 11056 | <1% | 25 | $7K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 102 | $7K |
| 94060 | <1% | 27 | $7K | |
| 90674 | <1% | 247 | $6K | |
| 92133 | <1% | 69 | $5K | |
| 51798 | <1% | 14 | $5K | |
| 93000 | <1% | 693 | $5K | |
| 1126F | <1% | 5,496 | $4K | |
| 81002 | <1% | 1,220 | $4K | |
| 82962 | <1% | 553 | $4K | |
| 57410 | <1% | 67 | $3K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 26 | $3K |
| 95251 | <1% | 41 | $3K | |
| 20610 | <1% | 14 | $3K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 215 | $2K |
| 99453 | <1% | 457 | $2K | |
| 92250 | <1% | 27 | $2K | |
| 80305 | <1% | 1,373 | $2K | |
| 10040 | <1% | 13 | $2K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 422 | $2K |
| G0008 | Administration of influenza virus vaccine | <1% | 215 | $2K |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 14 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,519 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 83 | $2K |
| 92015 | Determination of refractive state | <1% | 474 | $2K |
| 99490 | Ccm add 20min | <1% | 291 | $2K |
| S0610 | Annual gynecological examination, new patient | <1% | 26 | $1K |
| 20553 | <1% | 57 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 215 | $1K |
| 99051 | <1% | 113 | $1K | |
| Q3014 | Telehealth originating site facility fee | <1% | 112 | $1K |
| 99459 | <1% | 26 | $1K | |
| 36000 | <1% | 40 | $1K | |
| 11719 | <1% | 14 | $887.51 | |
| 92134 | <1% | 12 | $655.01 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 228 | $579.55 |
| 87070 | <1% | 157 | $518.60 | |
| 3074F | <1% | 3,951 | $518.50 | |
| 99458 | <1% | 354 | $510.35 | |
| 99050 | <1% | 80 | $506.76 | |
| 1125F | <1% | 2,422 | $390.80 | |
| 90661 | <1% | 12 | $360.76 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 968 | $360.49 |
| 3079F | <1% | 1,936 | $355.16 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 942 | $339.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 30 | $332.24 |
| 99348 | <1% | 75 | $284.22 | |
| 3078F | <1% | 3,222 | $270.49 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,269 | $263.85 |
| 2001F | <1% | 6,189 | $183.02 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 3,670 | $150.40 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 15 | $150.00 |
| 99344 | <1% | 14 | $130.25 | |
| 96127 | <1% | 114 | $113.68 | |
| G9744 | Patient not eligible due to active diagnosis of hypertension | <1% | 447 | $106.08 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | <1% | 304 | $103.36 |
| 81025 | <1% | 33 | $97.01 | |
| 3077F | <1% | 907 | $92.50 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 4,523 | $88.68 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 257 | $88.40 |
| 3080F | <1% | 604 | $80.00 | |
| 3075F | <1% | 769 | $77.50 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 1,510 | $39.11 |
| 3028F | <1% | 6,804 | $38.21 | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 38 | $28.19 |
| 1160F | <1% | 5,795 | $24.70 | |
| 2010F | <1% | 6,553 | $22.72 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 567 | $10.27 |
| 3044F | <1% | 927 | $5.99 | |
| G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | <1% | 1,369 | $3.19 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 81 | $0.86 |
| G8783 | Normal blood pressure reading documented, follow-up not required | <1% | 1,814 | $0.28 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 392 | $0.07 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,278 | $0.07 |
| G4028 | Podiatry mips specialty set | <1% | 542 | $0.06 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | <1% | 528 | $0.05 |
| G4018 | Obstetrics/gynecology mips specialty set | <1% | 818 | $0.03 |
| 3008F | <1% | 7,209 | $0.01 | |
| 1036F | <1% | 2,618 | $0.01 | |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | <1% | 73 | $0.01 |
| 2018F | <1% | 1,835 | $0.01 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 76 | $0.01 |
| 3754F | 0% | 230 | $0.00 | |
| 1170F | 0% | 159 | $0.00 | |
| 3048F | 0% | 412 | $0.00 | |
| J0280 | Injection, aminophyllin, up to 250 mg | 0% | 12 | $0.00 |
| 4011F | 0% | 214 | $0.00 | |
| 4010F | 0% | 89 | $0.00 | |
| 1034F | 0% | 557 | $0.00 | |
| 3279F | 0% | 263 | $0.00 | |
| 3514F | 0% | 68 | $0.00 | |
| 3049F | 0% | 192 | $0.00 | |
| M1207 | Patient is screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety | 0% | 106 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 693 | $0.00 |
| 3510F | 0% | 69 | $0.00 | |
| 1006F | 0% | 64 | $0.00 | |
| G2197 | Patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user | 0% | 113 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 30 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 54 | $0.00 |
| 1000F | 0% | 193 | $0.00 | |
| 3011F | 0% | 244 | $0.00 | |
| 4008F | 0% | 47 | $0.00 | |
| 1220F | 0% | 17 | $0.00 | |
| 90656 | 0% | 14 | $0.00 | |
| 3512F | 0% | 65 | $0.00 | |
| 3120F | 0% | 25 | $0.00 | |
| G8404 | Lower extremity neurological exam performed and documented | 0% | 525 | $0.00 |
| 2029F | 0% | 551 | $0.00 | |
| 4004F | 0% | 367 | $0.00 | |
| 2028F | 0% | 547 | $0.00 | |
| 1137F | 0% | 565 | $0.00 | |
| 1090F | 0% | 75 | $0.00 | |
| 3725F | 0% | 376 | $0.00 | |
| 3511F | 0% | 377 | $0.00 | |
| 4013F | 0% | 692 | $0.00 | |
| 1033F | 0% | 634 | $0.00 | |
| 3280F | 0% | 180 | $0.00 | |
| 3513F | 0% | 68 | $0.00 | |
| 3015F | 0% | 190 | $0.00 | |
| 3016F | 0% | 143 | $0.00 | |
| 1100F | 0% | 64 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 16 | $0.00 |
| 3050F | 0% | 140 | $0.00 | |
| 4025F | 0% | 23 | $0.00 | |
| G9796 | Patient is currently on a high intensity statin therapy | 0% | 13 | $0.00 |
| 3020F | 0% | 27 | $0.00 | |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | 0% | 14 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLIPSCHITZ, DAVID (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| The Doral Investors Group, LLC Dba House Calls Home Care | Brooklyn, NY | $497.09M |
| The Doral Investors Group LLC | Brooklyn, NY | $34.29M |
| Alpha & Omega Kids Developmental Services | Brooklyn, NY | $11.94M |
| Doral Dialysis LLC | Brooklyn, NY | $252K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.